Latest Healthcare Research Reports

Tag: enteric softgel capsules market trends

  • Enteric Softgel Capsules Market Forecast Highlights Expansion From $2.55 Billion To $3.05 Billion Through 2030

    Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

    Enteric Softgel Capsules Market Expansion From $2.55 Billion In 2026 To $3.05 Billion In 2030

    The market for enteric softgel capsules has experienced consistent expansion, projected to increase from $2.44 billion in 2025 to $2.55 billion in 2026, reflecting a compound annual growth rate of 4.7%. This upward trend during the past period was fueled by escalating demand for digestive health supplements, a growing preference for oral drug delivery methods, significant advancements in softgel formulation techniques, heightened consumer awareness regarding health and wellness, and ongoing innovation in pharmaceutical dosages.

    The market for enteric softgel capsules is projected for consistent expansion in the coming years, anticipating a rise to $3.05 billion by 2030, fueled by a compound annual growth rate of 4.6%. This growth trajectory during the forecast period is anticipated to be bolstered by several key factors, including an increasing demand for vegan capsule options, the burgeoning field of personalized nutrition, advancements in the development of controlled-release formulations, the expanding scope of pharmaceutical outsourcing, and a heightened emphasis on preventive healthcare. Concurrently, prominent market trends expected to shape this period include a growing need for targeted drug delivery systems, an uptick in nutraceutical consumption, a greater utilization of acid-resistant formulations, the broadened acceptance and use of plant-based capsules, and a continuous focus on enhancing bioavailability.

    Download A Free Sample Report For Comprehensive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=20775&type=smp

    Enteric Softgel Capsules Market Expansion Supported By Key Demand Factors

    Rising instances of nutritional imbalances, stemming from inadequate or excessive intake of vital vitamins, minerals, proteins, fats, and carbohydrates, are projected to be a key catalyst for the expansion of the enteric softgel capsules market. These nutritional disorders are exacerbated by prevalent unhealthy eating patterns, inactive lifestyles, restricted availability of wholesome foods, a greater reliance on processed food products, and socioeconomic hurdles that impede appropriate nourishment. Enteric softgel capsules play a crucial role in addressing these disorders by facilitating the delivery of essential nutrients, safeguarding them from the acidic environment of the stomach and ensuring their phased release within the intestines, thus optimizing absorption, enhancing nutrient bioavailability, and promoting better gastrointestinal function and nutritional equilibrium. As an illustration, a 2024 publication by the Food and Agriculture Organization, a Canada-based international body, highlighted that global undernourishment persisted at 9.1 percent in 2023, with 11.5 percent of the populace experiencing food insecurity during the same year, underscoring the growing demand for solutions like enteric softgel capsules in managing these widespread nutritional challenges.

    Enteric Softgel Capsules Market Segment Analysis And Revenue Opportunities

    The enteric softgel capsules market covered in this report is segmented –

    1) By Type: Gelatin Capsules, Non-Gelatin Softgel Capsules

    2) By Distribution Channel: Supermarkets And Hypermarkets, Pharmacy And Drug Stores, Online Stores

    3) By Application: Antacid And Antiflatulent Preparations, Anti-Inflammatory Drugs, Antibiotic And Antibacterial Drugs, Cough And Cold Preparations, Health Supplements, Vitamin And Dietary Supplements, Other Therapeutic Applications

    4) By End User: Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies, Food Industry

    Subsegments:

    1) By Gelatin Capsules: Bovine Gelatin Softgel Capsules, Porcine Gelatin Softgel Capsules, Fish Gelatin Softgel Capsules

    2) By Non-Gelatin Softgel Capsules: Plant-Based Softgel Capsules, Vegan Softgel Capsules, Polymer-Based Softgel Capsules

    Enteric Softgel Capsules Market Growth Trends Influencing Competitive Dynamics

    Within the enteric softgel capsules market, significant players are actively engaged in innovation, specifically concentrating on sophisticated solutions like plant-derived excipient systems designed for intestinal release that are resistant to stomach acid. These advancements aim to boost product stability, enhance the absorption of active compounds, and cater to demands for clean-label and vegan products. A plant-based excipient system, which utilizes polymers not sourced from animals – exemplified by hydroxypropyl pea starch – constructs capsules capable of withstanding gastric acidity and facilitating therapeutic release in the intestinal tract. This contrasts with conventional gelatin softgels, which might dissolve prematurely in the stomach, potentially compromising acid-sensitive ingredients. To illustrate, Roquette, a French provider of plant-based ingredients, introduced LYCAGEL in April 2024. This hydroxypropyl pea starch excipient empowers producers to formulate vegan, clean-label softgels exhibiting acid resistance, thereby safeguarding delicate nutraceuticals like omega-3 fatty acids and probiotics, optimizing bioavailability, and obviating the necessity of gelatin.

    Enteric Softgel Capsules Market Leading Players Shaping Industry Direction

    Major companies operating in the enteric softgel capsules market are BASF SE, United Laboratories International Inc., Herbalife Nutrition Ltd., Catalent Pharma Solutions Inc., Sirio Pharma Co. Ltd., NOW Health Group Inc., Patheon, GELITA AG, Colorcon Inc., Aenova Group GmbH, ProCaps Laboratories Inc., CAPTEK Softgel International Inc., Renown Pharmaceuticals Private Limited, Viva Pharmaceutical Inc., Biofield Pharma Private Limited, CapsCanada Corporation, Natural Capsules Limited, Fuji Capsules Co. Ltd., Conch Lifescience Co. Ltd., Lonza Group Ltd., EuroCaps Ltd., Strides Pharma Science Limited, Emcure Pharmaceuticals Limited, Soft Gel Technologies Inc.

    Access The Complete Enteric Softgel Capsules Market Report:

    https://www.thebusinessresearchcompany.com/report/enteric-softgel-capsules-global-market-report

    Enteric Softgel Capsules Market Geographic Distribution And Regional Opportunities

    North Americawas the largest region in the enteric softgel capsules market in 2025. The regions covered in the enteric softgel capsules market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Enteric Softgel Capsules Market Forecast Highlights Expansion From $2.55 Billion To $3.05 Billion Through 2030

    Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

    Enteric Softgel Capsules Market Expansion From $2.55 Billion In 2026 To $3.05 Billion In 2030

    The market for enteric softgel capsules has experienced consistent expansion, projected to increase from $2.44 billion in 2025 to $2.55 billion in 2026, reflecting a compound annual growth rate of 4.7%. This upward trend during the past period was fueled by escalating demand for digestive health supplements, a growing preference for oral drug delivery methods, significant advancements in softgel formulation techniques, heightened consumer awareness regarding health and wellness, and ongoing innovation in pharmaceutical dosages.

    The market for enteric softgel capsules is projected for consistent expansion in the coming years, anticipating a rise to $3.05 billion by 2030, fueled by a compound annual growth rate of 4.6%. This growth trajectory during the forecast period is anticipated to be bolstered by several key factors, including an increasing demand for vegan capsule options, the burgeoning field of personalized nutrition, advancements in the development of controlled-release formulations, the expanding scope of pharmaceutical outsourcing, and a heightened emphasis on preventive healthcare. Concurrently, prominent market trends expected to shape this period include a growing need for targeted drug delivery systems, an uptick in nutraceutical consumption, a greater utilization of acid-resistant formulations, the broadened acceptance and use of plant-based capsules, and a continuous focus on enhancing bioavailability.

    Download A Free Sample Report For Comprehensive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=20775&type=smp

    Enteric Softgel Capsules Market Expansion Supported By Key Demand Factors

    Rising instances of nutritional imbalances, stemming from inadequate or excessive intake of vital vitamins, minerals, proteins, fats, and carbohydrates, are projected to be a key catalyst for the expansion of the enteric softgel capsules market. These nutritional disorders are exacerbated by prevalent unhealthy eating patterns, inactive lifestyles, restricted availability of wholesome foods, a greater reliance on processed food products, and socioeconomic hurdles that impede appropriate nourishment. Enteric softgel capsules play a crucial role in addressing these disorders by facilitating the delivery of essential nutrients, safeguarding them from the acidic environment of the stomach and ensuring their phased release within the intestines, thus optimizing absorption, enhancing nutrient bioavailability, and promoting better gastrointestinal function and nutritional equilibrium. As an illustration, a 2024 publication by the Food and Agriculture Organization, a Canada-based international body, highlighted that global undernourishment persisted at 9.1 percent in 2023, with 11.5 percent of the populace experiencing food insecurity during the same year, underscoring the growing demand for solutions like enteric softgel capsules in managing these widespread nutritional challenges.

    Enteric Softgel Capsules Market Segment Analysis And Revenue Opportunities

    The enteric softgel capsules market covered in this report is segmented –

    1) By Type: Gelatin Capsules, Non-Gelatin Softgel Capsules

    2) By Distribution Channel: Supermarkets And Hypermarkets, Pharmacy And Drug Stores, Online Stores

    3) By Application: Antacid And Antiflatulent Preparations, Anti-Inflammatory Drugs, Antibiotic And Antibacterial Drugs, Cough And Cold Preparations, Health Supplements, Vitamin And Dietary Supplements, Other Therapeutic Applications

    4) By End User: Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies, Food Industry

    Subsegments:

    1) By Gelatin Capsules: Bovine Gelatin Softgel Capsules, Porcine Gelatin Softgel Capsules, Fish Gelatin Softgel Capsules

    2) By Non-Gelatin Softgel Capsules: Plant-Based Softgel Capsules, Vegan Softgel Capsules, Polymer-Based Softgel Capsules

    Enteric Softgel Capsules Market Growth Trends Influencing Competitive Dynamics

    Within the enteric softgel capsules market, significant players are actively engaged in innovation, specifically concentrating on sophisticated solutions like plant-derived excipient systems designed for intestinal release that are resistant to stomach acid. These advancements aim to boost product stability, enhance the absorption of active compounds, and cater to demands for clean-label and vegan products. A plant-based excipient system, which utilizes polymers not sourced from animals – exemplified by hydroxypropyl pea starch – constructs capsules capable of withstanding gastric acidity and facilitating therapeutic release in the intestinal tract. This contrasts with conventional gelatin softgels, which might dissolve prematurely in the stomach, potentially compromising acid-sensitive ingredients. To illustrate, Roquette, a French provider of plant-based ingredients, introduced LYCAGEL in April 2024. This hydroxypropyl pea starch excipient empowers producers to formulate vegan, clean-label softgels exhibiting acid resistance, thereby safeguarding delicate nutraceuticals like omega-3 fatty acids and probiotics, optimizing bioavailability, and obviating the necessity of gelatin.

    Enteric Softgel Capsules Market Leading Players Shaping Industry Direction

    Major companies operating in the enteric softgel capsules market are BASF SE, United Laboratories International Inc., Herbalife Nutrition Ltd., Catalent Pharma Solutions Inc., Sirio Pharma Co. Ltd., NOW Health Group Inc., Patheon, GELITA AG, Colorcon Inc., Aenova Group GmbH, ProCaps Laboratories Inc., CAPTEK Softgel International Inc., Renown Pharmaceuticals Private Limited, Viva Pharmaceutical Inc., Biofield Pharma Private Limited, CapsCanada Corporation, Natural Capsules Limited, Fuji Capsules Co. Ltd., Conch Lifescience Co. Ltd., Lonza Group Ltd., EuroCaps Ltd., Strides Pharma Science Limited, Emcure Pharmaceuticals Limited, Soft Gel Technologies Inc.

    Access The Complete Enteric Softgel Capsules Market Report:

    https://www.thebusinessresearchcompany.com/report/enteric-softgel-capsules-global-market-report

    Enteric Softgel Capsules Market Geographic Distribution And Regional Opportunities

    North Americawas the largest region in the enteric softgel capsules market in 2025. The regions covered in the enteric softgel capsules market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Enteric Softgel Capsules Market Forecast Highlights Expansion From $2.55 Billion To $3.05 Billion Through 2030

    Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

    Enteric Softgel Capsules Market Expansion From $2.55 Billion In 2026 To $3.05 Billion In 2030

    The market for enteric softgel capsules has experienced consistent expansion, projected to increase from $2.44 billion in 2025 to $2.55 billion in 2026, reflecting a compound annual growth rate of 4.7%. This upward trend during the past period was fueled by escalating demand for digestive health supplements, a growing preference for oral drug delivery methods, significant advancements in softgel formulation techniques, heightened consumer awareness regarding health and wellness, and ongoing innovation in pharmaceutical dosages.

    The market for enteric softgel capsules is projected for consistent expansion in the coming years, anticipating a rise to $3.05 billion by 2030, fueled by a compound annual growth rate of 4.6%. This growth trajectory during the forecast period is anticipated to be bolstered by several key factors, including an increasing demand for vegan capsule options, the burgeoning field of personalized nutrition, advancements in the development of controlled-release formulations, the expanding scope of pharmaceutical outsourcing, and a heightened emphasis on preventive healthcare. Concurrently, prominent market trends expected to shape this period include a growing need for targeted drug delivery systems, an uptick in nutraceutical consumption, a greater utilization of acid-resistant formulations, the broadened acceptance and use of plant-based capsules, and a continuous focus on enhancing bioavailability.

    Download A Free Sample Report For Comprehensive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=20775&type=smp

    Enteric Softgel Capsules Market Expansion Supported By Key Demand Factors

    Rising instances of nutritional imbalances, stemming from inadequate or excessive intake of vital vitamins, minerals, proteins, fats, and carbohydrates, are projected to be a key catalyst for the expansion of the enteric softgel capsules market. These nutritional disorders are exacerbated by prevalent unhealthy eating patterns, inactive lifestyles, restricted availability of wholesome foods, a greater reliance on processed food products, and socioeconomic hurdles that impede appropriate nourishment. Enteric softgel capsules play a crucial role in addressing these disorders by facilitating the delivery of essential nutrients, safeguarding them from the acidic environment of the stomach and ensuring their phased release within the intestines, thus optimizing absorption, enhancing nutrient bioavailability, and promoting better gastrointestinal function and nutritional equilibrium. As an illustration, a 2024 publication by the Food and Agriculture Organization, a Canada-based international body, highlighted that global undernourishment persisted at 9.1 percent in 2023, with 11.5 percent of the populace experiencing food insecurity during the same year, underscoring the growing demand for solutions like enteric softgel capsules in managing these widespread nutritional challenges.

    Enteric Softgel Capsules Market Segment Analysis And Revenue Opportunities

    The enteric softgel capsules market covered in this report is segmented –

    1) By Type: Gelatin Capsules, Non-Gelatin Softgel Capsules

    2) By Distribution Channel: Supermarkets And Hypermarkets, Pharmacy And Drug Stores, Online Stores

    3) By Application: Antacid And Antiflatulent Preparations, Anti-Inflammatory Drugs, Antibiotic And Antibacterial Drugs, Cough And Cold Preparations, Health Supplements, Vitamin And Dietary Supplements, Other Therapeutic Applications

    4) By End User: Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies, Food Industry

    Subsegments:

    1) By Gelatin Capsules: Bovine Gelatin Softgel Capsules, Porcine Gelatin Softgel Capsules, Fish Gelatin Softgel Capsules

    2) By Non-Gelatin Softgel Capsules: Plant-Based Softgel Capsules, Vegan Softgel Capsules, Polymer-Based Softgel Capsules

    Enteric Softgel Capsules Market Growth Trends Influencing Competitive Dynamics

    Within the enteric softgel capsules market, significant players are actively engaged in innovation, specifically concentrating on sophisticated solutions like plant-derived excipient systems designed for intestinal release that are resistant to stomach acid. These advancements aim to boost product stability, enhance the absorption of active compounds, and cater to demands for clean-label and vegan products. A plant-based excipient system, which utilizes polymers not sourced from animals – exemplified by hydroxypropyl pea starch – constructs capsules capable of withstanding gastric acidity and facilitating therapeutic release in the intestinal tract. This contrasts with conventional gelatin softgels, which might dissolve prematurely in the stomach, potentially compromising acid-sensitive ingredients. To illustrate, Roquette, a French provider of plant-based ingredients, introduced LYCAGEL in April 2024. This hydroxypropyl pea starch excipient empowers producers to formulate vegan, clean-label softgels exhibiting acid resistance, thereby safeguarding delicate nutraceuticals like omega-3 fatty acids and probiotics, optimizing bioavailability, and obviating the necessity of gelatin.

    Enteric Softgel Capsules Market Leading Players Shaping Industry Direction

    Major companies operating in the enteric softgel capsules market are BASF SE, United Laboratories International Inc., Herbalife Nutrition Ltd., Catalent Pharma Solutions Inc., Sirio Pharma Co. Ltd., NOW Health Group Inc., Patheon, GELITA AG, Colorcon Inc., Aenova Group GmbH, ProCaps Laboratories Inc., CAPTEK Softgel International Inc., Renown Pharmaceuticals Private Limited, Viva Pharmaceutical Inc., Biofield Pharma Private Limited, CapsCanada Corporation, Natural Capsules Limited, Fuji Capsules Co. Ltd., Conch Lifescience Co. Ltd., Lonza Group Ltd., EuroCaps Ltd., Strides Pharma Science Limited, Emcure Pharmaceuticals Limited, Soft Gel Technologies Inc.

    Access The Complete Enteric Softgel Capsules Market Report:

    https://www.thebusinessresearchcompany.com/report/enteric-softgel-capsules-global-market-report

    Enteric Softgel Capsules Market Geographic Distribution And Regional Opportunities

    North Americawas the largest region in the enteric softgel capsules market in 2025. The regions covered in the enteric softgel capsules market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Enteric softgel capsules market to reach $3.05B by 2030 at 4.6% CAGR

    Enteric softgel capsules market to reach $3.05B by 2030 at 4.6% CAGR

    The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

    How Much Will The Market Value Of The Enteric Softgel Capsules Market Grow Between 2026 And 2030?

    The enteric softgel capsules market size has shown consistent growth over recent years. It is anticipated to increase from $2.44 billion in 2025 to $2.55 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 4.7%. The expansion observed historically can be ascribed to several factors, including digestive health supplement demand, oral drug delivery preference, softgel formulation advances, consumer health awareness, and pharmaceutical dosage innovation.

    The market for enteric softgel capsules is anticipated to experience consistent expansion over the upcoming period. Its value is projected to reach $3.05 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 4.6%. This anticipated growth during the forecast timeframe stems from factors such as increasing demand for vegan capsules, the expansion of personalized nutrition, advancements in controlled-release formulations, the broader adoption of pharmaceutical outsourcing, and a heightened emphasis on preventive healthcare. Key trends foreseen for this period encompass a growing need for targeted drug delivery, an uptick in nutraceutical consumption, wider application of acid-resistant formulations, the increasing embrace of plant-based capsules, and an intensified focus on enhancing bioavailability.

    Access Your Free Sample Report For In-Depth Market Analysis:

    https://www.thebusinessresearchcompany.com/report/enteric-softgel-capsules-global-market-report

    Which Primary Drivers Are Impacting The Enteric Softgel Capsules Market Growth?

    The rising occurrence of nutrition disorders is anticipated to propel the growth of the enteric softgel capsules market going forward. These conditions are characterized by imbalances in nutrient intake, resulting from either deficiencies or excesses of essential vitamins, minerals, proteins, fats, and carbohydrates. The increasing prevalence of nutrition disorders is fueled by factors such as poor dietary habits, inactive lifestyles, limited access to nutritious food, growing consumption of processed foods, and socio-economic difficulties that hinder proper nutrition. Enteric softgel capsules aid in managing these disorders by delivering vital nutrients while protecting them from stomach acid, ensuring their targeted release in the intestines for optimal absorption. This process enhances nutrient bioavailability and supports overall digestive health and nutritional balance. For instance, in 2024, a report by the Food and Agriculture Organization, a Canada-based specialized agency, revealed that global undernourishment stood at 9.1 percent in 2023. Furthermore, food insecurity affected 11.5 percent of the population in 2023. Consequently, the escalating incidence of nutrition disorders is driving the growth of the enteric softgel capsules market.

    How Is The Enteric Softgel Capsules Market Organized By Segment Classification?

    The enteric softgel capsules market covered in this report is segmented –

    1) By Type: Gelatin Capsules, Non-Gelatin Softgel Capsules

    2) By Distribution Channel: Supermarkets And Hypermarkets, Pharmacy And Drug Stores, Online Stores

    3) By Application: Antacid And Antiflatulent Preparations, Anti-Inflammatory Drugs, Antibiotic And Antibacterial Drugs, Cough And Cold Preparations, Health Supplements, Vitamin And Dietary Supplements, Other Therapeutic Applications

    4) By End User: Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies, Food Industry

    Subsegments:

    1) By Gelatin Capsules: Bovine Gelatin Softgel Capsules, Porcine Gelatin Softgel Capsules, Fish Gelatin Softgel Capsules

    2) By Non-Gelatin Softgel Capsules: Plant-Based Softgel Capsules, Vegan Softgel Capsules, Polymer-Based Softgel Capsules

    Which Trends Are Shaping Growth In The Enteric Softgel Capsules Market?

    Major companies operating in the enteric softgel capsules market are concentrating on developing technological advancements, particularly plant-based softgel excipient systems for acid-resistant intestinal release. This initiative aims to enhance stability, improve bioavailability, and support clean-label, vegan formulations. A plant-based softgel excipient system functions by utilizing non-animal-derived polymers, such as hydroxypropyl pea starch, to form shells that withstand stomach acid and release active ingredients in the intestine. This contrasts with traditional gelatin softgels, which may dissolve in the stomach, potentially degrading acid-sensitive actives. For example, in April 2024, Roquette, a France-based plant-based ingredient supplier, introduced LYCAGEL, a hydroxypropyl pea starch excipient tailored for plant-based softgels. This product enables manufacturers to produce vegan, clean-label softgels with acid-resistant properties, safeguarding sensitive nutraceuticals like omega-3s and probiotics, improving bioavailability, and removing the need for gelatin.

    Who Are The Industry Participants Involved In The Enteric Softgel Capsules Market?

    Major companies operating in the enteric softgel capsules market are BASF SE, United Laboratories International Inc., Herbalife Nutrition Ltd., Catalent Pharma Solutions Inc., Sirio Pharma Co. Ltd., NOW Health Group Inc., Patheon, GELITA AG, Colorcon Inc., Aenova Group GmbH, ProCaps Laboratories Inc., CAPTEK Softgel International Inc., Renown Pharmaceuticals Private Limited, Viva Pharmaceutical Inc., Biofield Pharma Private Limited, CapsCanada Corporation, Natural Capsules Limited, Fuji Capsules Co. Ltd., Conch Lifescience Co. Ltd., Lonza Group Ltd., EuroCaps Ltd., Strides Pharma Science Limited, Emcure Pharmaceuticals Limited, Soft Gel Technologies Inc.

    Get The Full Enteric Softgel Capsules Market Report:

    https://www.thebusinessresearchcompany.com/report/enteric-softgel-capsules-global-market-report

    Where Is The Enteric Softgel Capsules Market Primarily Concentrated By Region?

    North America was the largest region in the enteric softgel capsules market in 2025. The regions covered in the enteric softgel capsules market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Customized Enteric Softgel Capsules Market Report For Competitive Insights:

    https://www.thebusinessresearchcompany.com/report/enteric-softgel-capsules-global-market-report

    Browse Through More Reports Similar to the Global Enteric Softgel Capsules Market 2026, By The Business Research Company

    Empty Capsules Market Report 2026

    https://www.thebusinessresearchcompany.com/report/empty-capsules-global-market-report

    Aerogel Market Report 2026

    https://www.thebusinessresearchcompany.com/report/aerogel-global-market-report

    Coffee Capsule Market Report 2026

    https://www.thebusinessresearchcompany.com/report/coffee-capsule-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Enteric Softgel Capsules Market Developments and Growth Opportunities Across 2026–2030

    Enteric Softgel Capsules Market Developments and Growth Opportunities Across 2026–2030

    The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

    What Is The Expected Market Size Of The Enteric Softgel Capsules Market From 2026 To 2030?

    The enteric softgel capsules market size has experienced consistent expansion in recent years. This market is projected to grow from $2.44 billion in 2025 to $2.55 billion in 2026, at a compound annual growth rate (CAGR) of 4.7%. The historical growth can be linked to the demand for digestive health supplements, the preference for oral drug delivery, advancements in softgel formulations, growing consumer health awareness, and innovations in pharmaceutical dosage.

    The enteric softgel capsules market size is projected to experience consistent expansion over the upcoming years, reaching $3.05 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 4.6%. This anticipated growth during the forecast period stems from factors such as vegan capsule demand, personalized nutrition growth, controlled-release formulation development, pharmaceutical outsourcing expansion, and a focus on preventive healthcare. Key developments anticipated in this period encompass a rising demand for targeted drug delivery, growth in nutraceutical consumption, increased use of acid-resistant formulations, expansion of plant-based capsule adoption, and an emphasis on improved bioavailability.

    Download the Free Sample Report to Explore Key Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=20775&type=smp

    What Drivers Are Influencing The Enteric Softgel Capsules Market?

    The growing occurrence of nutrition disorders is anticipated to propel the expansion of the enteric softgel capsules market moving forward. Nutritional disorders are conditions resulting from an imbalance in nutrient intake, whether from a deficit or an excess of essential vitamins, minerals, proteins, fats, and carbohydrates. The rising incidence of these disorders is fueled by factors such as poor dietary habits, inactive lifestyles, limited access to nutritious food, increased consumption of processed foods, and socio-economic obstacles that impede proper nutrition. Enteric softgel capsules aid in managing nutritional disorders by delivering vital nutrients in a way that safeguards them from stomach acid, ensuring their targeted release in the intestines where absorption is most efficient. This process improves nutrient bioavailability and supports overall digestive health and nutritional balance. For instance, in 2024, a report from the Food and Agriculture Organization, a Canada-based specialized agency, indicated that global undernourishment remained at 9.1 percent in 2023. Furthermore, food insecurity affected 11.5 percent of the population in 2023. Consequently, the increasing incidence of nutrition disorders is driving the growth of the enteric softgel capsules market.

    Which Segments Are Included In The Analysis Of The Enteric Softgel Capsules Market?

    The enteric softgel capsules market covered in this report is segmented –

    1) By Type: Gelatin Capsules, Non-Gelatin Softgel Capsules

    2) By Distribution Channel: Supermarkets And Hypermarkets, Pharmacy And Drug Stores, Online Stores

    3) By Application: Antacid And Antiflatulent Preparations, Anti-Inflammatory Drugs, Antibiotic And Antibacterial Drugs, Cough And Cold Preparations, Health Supplements, Vitamin And Dietary Supplements, Other Therapeutic Applications

    4) By End User: Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies, Food Industry

    Subsegments:

    1) By Gelatin Capsules: Bovine Gelatin Softgel Capsules, Porcine Gelatin Softgel Capsules, Fish Gelatin Softgel Capsules

    2) By Non-Gelatin Softgel Capsules: Plant-Based Softgel Capsules, Vegan Softgel Capsules, Polymer-Based Softgel Capsules

    What Trends Are Advancing Progress In The Enteric Softgel Capsules Market?

    Leading firms within the enteric softgel capsules market are concentrating on innovating, specifically by advancing plant-based softgel excipient systems designed for acid-resistant intestinal release. These innovations aim to boost stability, increase bioavailability, and facilitate clean-label, vegan products. Such plant-derived softgel excipient systems utilize polymers not sourced from animals, like hydroxypropyl pea starch, to create shells that withstand stomach acid, ensuring active components are released in the intestine. This offers a distinct advantage over conventional gelatin softgels, which can dissolve prematurely in the stomach, potentially compromising acid-sensitive ingredients. An example of this trend is seen in April 2024, when Roquette, a plant-based ingredient provider based in France, introduced LYCAGEL, an excipient derived from hydroxypropyl pea starch for use in plant-based softgels. This offering empowers manufacturers to produce vegan, clean-label softgels featuring acid-resistant properties, safeguarding delicate nutraceuticals such as omega-3s and probiotics, while also enhancing bioavailability and removing the requirement for gelatin.

    Which Key Industry Participants Are Active In The Enteric Softgel Capsules Market?

    Major companies operating in the enteric softgel capsules market are BASF SE, United Laboratories International Inc., Herbalife Nutrition Ltd., Catalent Pharma Solutions Inc., Sirio Pharma Co. Ltd., NOW Health Group Inc., Patheon, GELITA AG, Colorcon Inc., Aenova Group GmbH, ProCaps Laboratories Inc., CAPTEK Softgel International Inc., Renown Pharmaceuticals Private Limited, Viva Pharmaceutical Inc., Biofield Pharma Private Limited, CapsCanada Corporation, Natural Capsules Limited, Fuji Capsules Co. Ltd., Conch Lifescience Co. Ltd., Lonza Group Ltd., EuroCaps Ltd., Strides Pharma Science Limited, Emcure Pharmaceuticals Limited, Soft Gel Technologies Inc.

    Read the full enteric softgel capsules market report here:

    https://www.thebusinessresearchcompany.com/report/enteric-softgel-capsules-global-market-report

    Which Regions Are Expected To Experience Rapid Expansion In The Enteric Softgel Capsules Market?

    North America was the largest region in the enteric softgel capsules market in 2025. The regions covered in the enteric softgel capsules market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Tailored Enteric Softgel Capsules Market Research Report For Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=20775&type=smp

    Browse Through More Reports Similar to the Global Enteric Softgel Capsules Market 2026, By The Business Research Company

    Gastrointestinal Pathogen Testing Global Market Report

    https://www.thebusinessresearchcompany.com/report/gastrointestinal-pathogen-testing-global-market-report

    Infectious Disease Diagnostics Testing Global Market Report

    https://www.thebusinessresearchcompany.com/report/infectious-disease-diagnostics-testing-global-market-report

    Food Pathogen Testing Global Market Report

    https://www.thebusinessresearchcompany.com/report/food-pathogen-testing-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Enteric Softgel Capsules Market Outlook: Growth and Forecast Highlights 2030

    Enteric Softgel Capsules Market Outlook: Growth and Forecast Highlights 2030

    Uncover key drivers, emerging technologies, and competitive movements shaping the enteric softgel capsules market from 2026–2035 with trusted insights from The Business Research Company

    What level of growth is expected in the Enteric Softgel Capsules Market between 2026 and 2030?

    The enteric softgel capsules market has experienced consistent growth over the past few years. It is forecast to expand from $2.44 billion in 2025 to $2.55 billion in 2026, displaying a compound annual growth rate (CAGR) of 4.7%. The historical increase can be attributed to factors such as demand for digestive health supplements, a preference for oral drug delivery, progress in softgel formulations, rising consumer health awareness, and pharmaceutical dosage innovation.

    The enteric softgel capsules market is projected to experience consistent expansion in the coming years. By 2030, its valuation is set to reach $3.05 billion, driven by a compound annual growth rate (CAGR) of 4.6%. This anticipated growth can be attributed to several factors such as the increasing demand for vegan capsules, the expansion of personalized nutrition, advancements in controlled-release formulations, the rise in pharmaceutical outsourcing, and a greater emphasis on preventive healthcare. Key developments expected during this period include a heightened demand for targeted drug delivery, an increase in nutraceutical consumption, wider adoption of acid-resistant formulations, the growing popularity of plant-based capsules, and a strong focus on enhancing bioavailability.

    Access Your Free Sample Report for In-Depth Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=20775&type=smp

    Which Drivers Are Expected To Impact The Enteric Softgel Capsules Market During The Forecast Period?

    The growing occurrence of nutrition disorders is anticipated to boost the enteric softgel capsules market in the future. These conditions stem from imbalances in nutrient intake, encompassing either deficits or excesses of vital vitamins, minerals, proteins, fats, and carbohydrates. The escalating prevalence of nutrition disorders is influenced by factors such as poor eating habits, inactive lifestyles, limited availability of nourishing food, increased consumption of processed foods, and socio-economic hurdles impeding proper nutrition. Enteric softgel capsules aid in addressing nutrition disorders by delivering essential nutrients, protecting them from stomach acid, and ensuring their targeted release in the intestines for optimal absorption. This process improves nutrient bioavailability and supports overall digestive health and nutritional balance. For example, a 2024 report by the Food and Agriculture Organization, a Canada-based specialized agency, stated that global undernourishment stayed at 9.1 percent in 2023. Moreover, food insecurity impacted 11.5 percent of the population in 2023. Therefore, the rising incidence of nutrition disorders is a key driver for the growth of the enteric softgel capsules market.

    Which Segments Are Driving Activity In The Enteric Softgel Capsules Market?

    The enteric softgel capsules market covered in this report is segmented –

    1) By Type: Gelatin Capsules, Non-Gelatin Softgel Capsules

    2) By Distribution Channel: Supermarkets And Hypermarkets, Pharmacy And Drug Stores, Online Stores

    3) By Application: Antacid And Antiflatulent Preparations, Anti-Inflammatory Drugs, Antibiotic And Antibacterial Drugs, Cough And Cold Preparations, Health Supplements, Vitamin And Dietary Supplements, Other Therapeutic Applications

    4) By End User: Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies, Food Industry

    Subsegments:

    1) By Gelatin Capsules: Bovine Gelatin Softgel Capsules, Porcine Gelatin Softgel Capsules, Fish Gelatin Softgel Capsules

    2) By Non-Gelatin Softgel Capsules: Plant-Based Softgel Capsules, Vegan Softgel Capsules, Polymer-Based Softgel Capsules

    Which Trends Are Shaping Activity Within The Enteric Softgel Capsules Market?

    Key players within the enteric softgel capsules market are prioritizing the creation of technological advancements like plant-based softgel excipient systems. These innovations are designed to facilitate acid-resistant intestinal release, thereby improving stability, enhancing bioavailability, and supporting clean-label, vegan formulations. A plant-based softgel excipient system functions by employing non-animal-derived polymers, such as hydroxypropyl pea starch, to construct shells that resist stomach acid and ensure active ingredients are released in the intestine. This differs from traditional gelatin softgels, which can dissolve in the stomach and potentially degrade acid-sensitive active components. Illustratively, in April 2024, Roquette, a France-based supplier of plant-based ingredients, launched LYCAGEL, an excipient based on hydroxypropyl pea starch for plant-based softgels. This product empowers manufacturers to develop vegan, clean-label softgels featuring acid-resistant capabilities, which protect vulnerable nutraceuticals like omega-3s and probiotics, boost their bioavailability, and remove the necessity for gelatin.

    Which Major Industry Participants Are Leading The Enteric Softgel Capsules Market Growth?

    Major companies operating in the enteric softgel capsules market are BASF SE, United Laboratories International Inc., Herbalife Nutrition Ltd., Catalent Pharma Solutions Inc., Sirio Pharma Co. Ltd., NOW Health Group Inc., Patheon, GELITA AG, Colorcon Inc., Aenova Group GmbH, ProCaps Laboratories Inc., CAPTEK Softgel International Inc., Renown Pharmaceuticals Private Limited, Viva Pharmaceutical Inc., Biofield Pharma Private Limited, CapsCanada Corporation, Natural Capsules Limited, Fuji Capsules Co. Ltd., Conch Lifescience Co. Ltd., Lonza Group Ltd., EuroCaps Ltd., Strides Pharma Science Limited, Emcure Pharmaceuticals Limited, Soft Gel Technologies Inc.

    Access The Complete Report For Deeper Market Insights:

    https://www.thebusinessresearchcompany.com/report/enteric-softgel-capsules-global-market-report

    Which Region Is Projected To Lead The Enteric Softgel Capsules Market During The Forecast Period?

    North America was the largest region in the enteric softgel capsules market in 2025. The regions covered in the enteric softgel capsules market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request Your Customized Enteric Softgel Capsules Market Research Report for Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=20775&type=smp

    Browse Through More Reports Similar to the Global Enteric Softgel Capsules Market 2026, By The Business Research Company

    Empty Capsules Market Report 2026

    https://www.thebusinessresearchcompany.com/report/empty-capsules-global-market-report

    Aerogel Market Report 2026

    https://www.thebusinessresearchcompany.com/report/aerogel-global-market-report

    Coffee Capsule Market Report 2026

    https://www.thebusinessresearchcompany.com/report/coffee-capsule-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • How Is The Enteric Softgel Capsules Market Expected To Grow At 4.6% CAGR Over 2025–2029?

    How Is The Enteric Softgel Capsules Market Expected To Grow At 4.6% CAGR Over 2025–2029?

    Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

    How Is The Enteric Softgel Capsules Market Expected To Grow In Terms Of Size?

    The market size of enteric softgel capsules has experienced consistent growth in the past few years. The market, which is expected to rise from $2.34 billion in 2024 to $2.44 billion in 2025, boasts a compound annual growth rate (CAGR) of 4.1%. Factors such as the surging demand for pharmaceutical products, heightened emphasis on health and nutrition, expansion in research and development efforts, increasing demand for softgel health supplements, and improved consumer awareness towards preventative healthcare, have all contributed to the historical growth.

    The market size of enteric softgel capsules is predicted to experience consistent expansion in the forthcoming years, escalating to a value of $2.92 billion by 2029 with a Compound Annual Growth Rate (CAGR) of 4.6%. This projected growth within the forecast period can be ascribed to numerous factors such as heightened focus on clinical trials, an increased dependence on online channels, greater emphasis on preemptive healthcare, a rise in the frequency of nutrition-related disorders, and burgeoning awareness. Key trends anticipated in this period encompass technological progress, emphasis on clinical trials, enhancements in production procedures, intensifying collaborations and noteworthy product innovation.

    Get A Free Sample Of The Report:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=20775&type=smp

    What Are The Primary Factors Supporting The Enteric Softgel Capsules Market Expansion?

    The rise in nutritional imbalances is anticipated to fuel the expansion of the enteric softgel capsules market. Nutritional imbalances involve conditions that arise due to irregularities in the intake of essential nutrients, either due to lack or excess of vital vitamins, minerals, proteins, fats, and carbohydrates. Factors such as unhealthy eating habits, inactive lifestyle, restricted access to healthy food, increased consumption of processed food, and socio-economic hurdles affecting proper nutrition drive the rise in nutrition disorders. By delivering crucial nutrients in a manner that shields them from stomach acid, enteric softgel capsules contribute to managing these disorders. This ensures the delivery is targeted in the intestines, where absorption is at its peak, enhancing nutrient bioavailability and boosting overall digestive health and nutritional equilibrium. For example, as per a report by the Food and Agriculture Organization, a specialized agency based in Canada, in July 2023, around 2.8% of the ECA population, or 26.2 million people, were severely affected by food insecurity in 2022. This was a marginal increase of 0.1 percentage points from the year before. Consequently, the rise in nutrition imbalances is stimulating the expansion of the enteric softgel capsules market.

    Which Segmentation Categories Are Highlighted In The Enteric Softgel Capsules Market Analysis?

    The enteric softgel capsulesmarket covered in this report is segmented –

    1) By Type: Gelatin Capsules; Non-Gelatin Softgel Capsules

    2) By Distribution Channel: Supermarkets And Hypermarkets; Pharmacy And Drug Stores; Online Stores

    3) By Application: Antacid And Antiflatulent Preparations; Anti-Inflammatory Drugs; Antibiotic And Antibacterial Drugs; Cough And Cold Preparations; Health Supplements; Vitamin And Dietary Supplements; Other Therapeutic Applications

    4) By End User: Pharmaceutical Companies; Nutraceutical Companies; Cosmeceutical Companies; Food Industry

    Subsegments:

    1) By Gelatin Capsules: Bovine Gelatin Softgel Capsules; Porcine Gelatin Softgel Capsules; Fish Gelatin Softgel Capsules

    2) By Non-Gelatin Softgel Capsules: Plant-based Softgel Capsules; Vegan Softgel Capsules; Polymer-Based Softgel Capsules

    Which Market Trends Are Expected To Define The Future Of The Enteric Softgel Capsules Market?

    Leading participants in the enteric softgel capsule market are concentrating on the advancement of novel technologies such as innovative plant-based enteric softgels, to augment bioavailability and cater to consumer preferences. Plant-based enteric softgels constitute capsules that utilize plant-derived substances instead of animal-originated gelatin and are created with an enteric coating. For example, Sirio Pharma Co, an American pharmaceutical private label products production company, in October 2022, introduced EnteriClear. This product is aimed at preventing the stomach’s degradation of acid-sensitive active constituents, thereby removing the necessity for conventional coating processes. It presents distinctive features including protection of acid-sensitive ingredients from stomach degradation without the use of traditional coatings, ensuring release in the intestines, enhanced bioavailability, and minimization of discomfort. EnteriClear is a plant-based, non-GMO, gluten and sugar-free technology that provides a stable and clear shell sans the requirement of cold chain storage, making it the perfect solution for nutraceutical brands.

    Which Organizations Are At The Forefront Of The Enteric Softgel Capsules Market?

    Major companies operating in the enteric softgel capsules market are BASF SE, Thermo Fisher Scientific Inc., United Laboratories International Inc., Herbalife Nutrition Ltd., Catalent Pharma Solutions Inc., Sirio Pharma Co. Ltd., NOW Health Group Inc., Patheon, GELITA AG, Colorcon Inc., Aenova Group GmbH, ProCaps Laboratories Inc., CAPTEK Softgel International Inc., Renown Pharmaceuticals Private Limited, Viva Pharmaceutical Inc., Biofield Pharma Private Limited, CapsCanada Corporation, Natural Capsules Limited, Fuji Capsules Co. Ltd., Conch Lifescience Co. Ltd.

    Access The Complete Report Here:

    https://www.thebusinessresearchcompany.com/report/enteric-softgel-capsules-global-market-report

    Which Geographic Regions Are Creating Strong Demand In The Enteric Softgel Capsules Market?

    North America was the largest region in the enteric softgel capsules market in 2024. The regions covered in the enteric softgel capsules market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Customize Your Report Here:

    https://www.thebusinessresearchcompany.com/customise?id=20775&type=smp

    Browse Through More Reports Similar to the Global Enteric Softgel Capsules Market 2025, By The Business Research Company

    Softgel Capsules Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/softgel-capsules-global-market-report

    Probiotics Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/probiotics-global-market-report

    Probiotics Dietary Supplements Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/probiotics-dietary-supplements-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Strong CAGR to Propel in the Enteric Softgel Capsules Market and Beyond upto $2.92 Billion by 2029

    Strong CAGR to Propel in the Enteric Softgel Capsules Market and Beyond upto $2.92 Billion by 2029

    Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

    What Are the Projected Market Size and Growth Rates for the Enteric Softgel Capsules Market From 2025 To 2029?

    The market for enteric softgel capsules has been experiencing a steady escalation in its size in the past few years. It is projected to expand from a market value of $2.34 billion in 2024 to $2.44 billion in 2025, growing at a Compound Annual Growth Rate (CAGR) of 4.1%. The historical period’s growth can be associated with rises in pharmaceutical product demand, a heightened emphasis on health and nutritional well-being, an increase in research and development activities, an augmented desire for soft gel health supplements and a growing consumer awareness regarding preventative healthcare.

    Steady expansion is projected for the enteric softgel capsules market in the coming years, with an estimated growth to$2.92 billion in 2029,” reflecting a compound annual growth rate (CAGR) of 4.6%. The anticipated growth during the forecast period is attributed to a heightened focus on clinical trials, a growing trust in online platforms, increased importance placed on preventive healthcare, a rising occurrence of nutritional disorders, and an amplified public awareness. Key trends anticipated for the forecast period encompass technological progress, a renewed focus on clinical trials, enhancements in the manufacturing process, more partnerships, and innovative products.

    Download a free sample to assess the report’s scope and structure:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=20775&type=smp

    Which Primay Drivers Are Accelerating Growth in the Enteric Softgel Capsules Market?

    The escalating prevalence of nutritional disorders is anticipated to fuel the expansion of the enteric softgel capsules industry. These disorders are conditions brought on by nutritional imbalances, either through a deficiency or an excess of crucial vitamins, minerals, proteins, fats, and carbohydrates. Factors contributing to the escalating incidence include unhealthy eating habits, inactive lifestyles, limited access to nutritious food, growing consumption of processed food, and socio-economic challenges inhibiting proper nutrition. Enteric softgel capsules are designed to manage these disorders, delivering essential nutrients in a way that shields them from stomach acid for targeted release in the intestines where absorption is best. This improves the bioavailability of the nutrients and promotes excellent digestive health and nutritional equilibrium. For example, per a July 2023 report by the Food and Agriculture Organization, a specialized agency in Canada, severe food insecurity affected about 2.8% of the ECA population in 2022, equivalent to 26.2 million people. This reflected a minor rise of 0.1 percentage points from the preceding year. As such, the rising prevalence of nutritional disorders is propelling the expansion of the enteric softgel capsules industry.

    Which Primary Segments of the Enteric Softgel Capsules Market Are Driving Growth and Industry Transformations?

    The enteric softgel capsulesmarket covered in this report is segmented –

    1) By Type: Gelatin Capsules; Non-Gelatin Softgel Capsules

    2) By Distribution Channel: Supermarkets And Hypermarkets; Pharmacy And Drug Stores; Online Stores

    3) By Application: Antacid And Antiflatulent Preparations; Anti-Inflammatory Drugs; Antibiotic And Antibacterial Drugs; Cough And Cold Preparations; Health Supplements; Vitamin And Dietary Supplements; Other Therapeutic Applications

    4) By End User: Pharmaceutical Companies; Nutraceutical Companies; Cosmeceutical Companies; Food Industry

    Subsegments:

    1) By Gelatin Capsules: Bovine Gelatin Softgel Capsules; Porcine Gelatin Softgel Capsules; Fish Gelatin Softgel Capsules

    2) By Non-Gelatin Softgel Capsules: Plant-based Softgel Capsules; Vegan Softgel Capsules; Polymer-Based Softgel Capsules

    Request customized data on this market:

    https://www.thebusinessresearchcompany.com/customise?id=20775&type=smp

    Which Regions Are Key Players in the Growth of the #Which Primay Drivers Are Accelerating Growth in the Enteric Softgel Capsules Market?# Market?

    North America was the largest region in the enteric softgel capsules market in 2024. The regions covered in the enteric softgel capsules market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Which Technological Trends Are Reshaping the Enteric Softgel Capsules Industry Dynamics?

    Major enterprises engaged in the enteric softgel capsule sector are concentrating their efforts on the invention of novel technologies, like new plant-originated enteric softgels, to improve bioavailability and attract consumers. These plant-based enteric softgels are capsules constructed from botanical substances instead of the usual animal gelatin and they come with an enteric layer. For instance, in October 2022, a production company named Sirio Pharma Co, which is based in the US, and is known for their manufacture of confidential pharmaceutical products, introduced EnteriClear, a product that shields acid-sensitive substances from suffering any damage in the stomach, eliminating the requirement for orthodox coating methods. It delivers unique features like protection of acid-sensitive components from deterioration inside the stomach without the common coatings, guaranteed intestinal release, better bioavailability, and minimized discomfort. In addition, this botanical, non-GMO, gluten-free, sugar-free technology presents a firm, transparent shell without the necessity for cold chain storage, making it perfect for nutraceutical brands.

    View the full report here:

    https://www.thebusinessresearchcompany.com/report/enteric-softgel-capsules-global-market-report

    What Parameters Are Used to Define the Enteric Softgel Capsules Market?

    Enteric softgel capsules are designed to have a protective coating that shields their contents from stomach acid, allowing them to dissolve in the small intestine for targeted release and absorption. This technology is commonly used for probiotics, fish oil, and medications to safeguard sensitive ingredients or reduce stomach irritation.

    Purchase the full report and get a swift delivery:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20775

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Europe +44 7882 955267

    Asia & Others +44 7882 955267 & +91 8897263534

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Enteric Softgel Capsules Market Projected at $2.99 Billion by 2029 | Strategic Insights and Forecast Data

    Enteric Softgel Capsules Market Projected at $2.99 Billion by 2029 | Strategic Insights and Forecast Data

    Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

    How Has the Enteric Softgel Capsules Market Size Changed, over the years?

    The market for enteric softgel capsules has experienced robust growth in recent times. Its market value is expected to rise from $2.34 billion in 2024 to reach $2.46 billion in 2025, reflecting a compound annual growth rate (CAGR) of 5.23%. This growth in the preceding period can be credited to factors such as the surging demand for pharmaceuticals, an amplified focus on health and nutrition, an escalation in R&D endeavors, an increase in demand for soft gel health supplements, and a surge in consumer awareness about preventive healthcare.

    How Much Will the Enteric Softgel Capsules Market Be Worth in 2029?

    The market for enteric softgel capsules is anticipated to experience consistent expansion in the upcoming years, with an expected valuation of $2.99 billion in 2029 and a compound annual growth rate (CAGR) of 4.97%. This growth during the forecast period can be traced back to factors such as a heightened emphasis on clinical trials, a growing dependency on online modes, a rising focus on preventive healthcare, an increased occurrence of nutrition-related disorders, and heightened awareness. Noteworthy trends during the forecast period encompass technological progression, attention to clinical trials, inventive alterations in the manufacturing procedure, rising collaborations, and innovation in products.

    Download The Free Sample Report Here:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=20775&type=smp

    Which is the Largest Company in the Enteric Softgel Capsules Market?

    Major companies operating in the enteric softgel capsules market are BASF SE, Thermo Fisher Scientific Inc., United Laboratories International Inc., Herbalife Nutrition Ltd., Catalent Pharma Solutions Inc., Sirio Pharma Co. Ltd., NOW Health Group Inc., Patheon, GELITA AG, Colorcon Inc., Aenova Group GmbH, ProCaps Laboratories Inc., CAPTEK Softgel International Inc., Renown Pharmaceuticals Private Limited, Viva Pharmaceutical Inc., Biofield Pharma Private Limited, CapsCanada Corporation, Natural Capsules Limited, Fuji Capsules Co. Ltd., Conch Lifescience Co. Ltd.

    What Are the Main Market Drivers in the Enteric Softgel Capsules Industry?

    The escalating occurrence of nutritional imbalances is predicted to boost the elevation of the enteric softgel capsules market. Nutritional imbalances, defined by disproportionate intake of key vitamins, minerals, proteins, fats, and carbohydrates, result in nutritional disorders. The escalation of these disorders is influenced by elements such as unhealthy eating practices, inactive living, inadequate access to nutritious food, an upsurge in processed food consumption, and socio-economic barriers preventing adequate nutrition. Enteric softgel capsules are beneficial in counteracting nutritional disorders by conveying vital nutrients, safeguarded from gastric acid, to the intestines, where absorption is superior, thereby augmenting nutrient bioavailability and endorsing overall digestive well-being and nutritional equilibrium. For example, in July 2023, the Food and Agriculture Organization, a Canada-based specialized agency, reported that in 2022, severe food insecurity touched roughly 2.8% of the ECA population, equating to around 26.2 million people, marking a marginal rise of 0.1 percentage points from the preceding year. Hence, the escalating prevalence of nutritional disorders is fueling the expansion of the enteric softgel capsules market.

    Request For A Customized Report:

    https://www.thebusinessresearchcompany.com/customise?id=20775&type=smp

    How Is the Enteric Softgel Capsules Market Segments Structured?

    The enteric softgel capsules market covered in this report is segmented –

    1) By Type: Gelatin Capsules, Non-Gelatin Softgel Capsules

    2) By Distribution Channel: Supermarkets And Hypermarkets, Pharmacy And Drug Stores, Online Stores

    3) By Application: Antacid And Antiflatulent Preparations, Anti-Inflammatory Drugs, Antibiotic And Antibacterial Drugs, Cough And Cold Preparations, Health Supplements, Vitamin And Dietary Supplements, Other Therapeutic Applications

    4) By End User: Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies, Food Industry

    Subsegments:

    1) By Gelatin Capsules: Bovine Gelatin Softgel Capsules, Porcine Gelatin Softgel Capsules, Fish Gelatin Softgel Capsules

    2) By Non-Gelatin Softgel Capsules: Plant-based Softgel Capsules, Vegan Softgel Capsules, Polymer-Based Softgel Capsules

    What Strategic Trends Are Transforming the Enteric Softgel Capsules Market?

    Leading enterprises in the enteric softgel capsule sector are leveraging their efforts towards creating advanced technologies like plant-based enteric softgels. This innovative development aims to boost bioavailability and appeal to consumers more. Enteric softgels derived from plants are being created from plant materials rather than those from animals, and these are designed with an enteric coating. An example of this is when Sirio Pharma Co—a US pharmaceutical private label product manufacturer—launched EnteriClear in October 2022. This product protects acid-sensitive elements from stomach degradation, removing the necessity for conventional coating processes. It provides unique advantages such as preventing acid-sensitive components from damage in the stomach without the typical coatings, guaranteeing intestinal release, enhanced bioavailability, and minimized discomfort. This non-GMO, sugar-free, gluten-free technology based on plants provides a stable, clear shell without needing cold chain storage— making it perfect for nutraceutical brands.

    Access The Full Report Here:

    https://www.thebusinessresearchcompany.com/report/enteric-softgel-capsules-global-market-report

    Which Global Regions Offer the Highest Growth in the Enteric Softgel Capsules Market?

    North America was the largest region in the enteric softgel capsules market in 2024. The regions covered in the enteric softgel capsules market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Purchase The Full Report Today:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20775

    This Report Delivers Insight On:

    1. How big is the enteric softgel capsules market, and how is it changing globally?

    2. Who are the major companies in the enteric softgel capsules market, and how are they performing?

    3. What are the key opportunities and risks in the enteric softgel capsules market right now?

    4. Which products or customer segments are growing the most in the enteric softgel capsules market?

    5. What factors are helping or slowing down the growth of the enteric softgel capsules market?

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Europe +44 7882 955267

    Asia & Others +44 7882 955267 & +91 8897263534

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Enteric Softgel Capsules Market Overview 2025: Competitive Shifts, Forecast Models, and Emerging Opportunities

    Enteric Softgel Capsules Market Overview 2025: Competitive Shifts, Forecast Models, and Emerging Opportunities

    Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.

    What Are the Key Milestones in the Enteric Softgel Capsules Market’s Growth Trajectory From 2025 To 2034?

    In the past few years, the market size for enteric softgel capsules has seen a significant surge. It is projected to expand from $2.34 billion in 2024 to $2.46 billion in 2025, with a compound annual growth rate (CAGR) of 5.23%. Various factors have propelled this growth during the historic period, including heightened demand for pharmaceutical products, a greater emphasis on health and nutrition, an upturn in research and development activities, increased interest in soft gel health supplements, and an enhanced consumer awareness about preventive healthcare.

    The market for enteric softgel capsules is projected to witness consistent expansion in the coming years, reaching a valuation of $2.99 billion by 2029, registering a compound annual growth rate (CAGR) of 4.97%. The projected growth during the forecast period can be ascribed to factors such as an amplified focus on clinical trials, a growing dependence on online channels, heightened emphasis on preventive healthcare, a rise in nutrition disorders, and broadening awareness. Key trends expected to shape the forecast period include technological breakthroughs, heightened concentration on clinical trials, innovations in the production process, an upsurge in partnerships, and product innovation.

    Download a free sample to assess the report’s scope and structure:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=20775&type=smp

    What Are the Core Growth Drivers Propelling the Enteric Softgel Capsules Market Forward?

    The rise in nutritional disorders is predicted to stimulate expansion in the enteric softgel capsules market. These disorders stem from imbalances in nutrient intake, such as deficiencies or excesses of crucial vitamins, minerals, proteins, fats, and carbohydrates. Factors promoting the rise in nutritional disorders include unhealthy eating habits, inactive lifestyles, limited availability of nutritious food, increased consumption of processed food, and socio-economic barriers to adequate nutrition. Enteric softgel capsules aid in controlling these disorders by providing essential nutrients in a method that safeguards them from stomach acid, offering targeted release in the intestines for most effective absorption, and thus enhancing nutrient bioavailability while promoting overall digestive health and nutritional equilibrium. For example, a report by the Food and Agriculture Organization, a specialized agency based in Canada, indicated in July 2023 that severe food insecurity affected roughly 2.8% of the ECA population, or around 26.2 million people, in 2022, a small rise of 0.1 percentage points from the prior year. Consequently, the escalating incidence of nutritional disorders is propelling the enteric softgel capsules market’s growth.

    What Segment Types Define the Enteric Softgel Capsules Market Structure?

    The enteric softgel capsules market covered in this report is segmented –

    1) By Type: Gelatin Capsules, Non-Gelatin Softgel Capsules

    2) By Distribution Channel: Supermarkets And Hypermarkets, Pharmacy And Drug Stores, Online Stores

    3) By Application: Antacid And Antiflatulent Preparations, Anti-Inflammatory Drugs, Antibiotic And Antibacterial Drugs, Cough And Cold Preparations, Health Supplements, Vitamin And Dietary Supplements, Other Therapeutic Applications

    4) By End User: Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies, Food Industry

    Subsegments:

    1) By Gelatin Capsules: Bovine Gelatin Softgel Capsules, Porcine Gelatin Softgel Capsules, Fish Gelatin Softgel Capsules

    2) By Non-Gelatin Softgel Capsules: Plant-based Softgel Capsules, Vegan Softgel Capsules, Polymer-Based Softgel Capsules

    Request customized data on this market:

    https://www.thebusinessresearchcompany.com/customise?id=20775&type=smp

    Which Geographic Areas Hold the Strongest Growth Potential in the Enteric Softgel Capsules Market?

    North America was the largest region in the enteric softgel capsules market in 2024. The regions covered in the enteric softgel capsules market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    What Are the Strategic Trends Steering the Enteric Softgel Capsules Market Direction?

    Key players in the enteric softgel capsule market are channelling their efforts into the creation of new and innovative technologies such as plant-based enteric softgels to boost bioavailability and appeal to consumers. Unlike its animal-based gelatin counterparts, plant-based enteric softgels are crafted using materials derived from plants and come with an enteric coating. For example, Sirio Pharma Co, a pharmaceutical private label product manufacturer based in the US, introduced EnteriClear in October 2022. It is a product devised to guard acid-sensitive ingredients against stomach degradation hence bypassing conventional coating methods. Some of its distinctive characteristics include shielding acid-sensitive elements from stomach degradation without the need for traditional coatings, guaranteed intestinal release, enhanced bioavailability, and less discomfort. Moreover, this plant-based, non-GMO, gluten-free, and sugar-free technology presents a clear, stable shell that does not need cold chain storage. This makes it optimally suited for nutraceutical brands.

    View the full report here:

    https://www.thebusinessresearchcompany.com/report/enteric-softgel-capsules-global-market-report

    What Is the Definition of the Enteric Softgel Capsules Market?

    Enteric softgel capsules are designed to have a protective coating that shields their contents from stomach acid, allowing them to dissolve in the small intestine for targeted release and absorption. This technology is commonly used for probiotics, fish oil, and medications to safeguard sensitive ingredients or reduce stomach irritation.

    Purchase the full report and get a swift delivery:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20775

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model